Makers Laboratories Limited (BOM:506919)

India · Delayed Price · Currency is INR

188.25

+1.25 (0.67%)

At close: Sep 25, 2026

Market Cap	1.11B +37.7%
Revenue (ttm)	1.49B +17.8%
Net Income	34.19M -61.6%
EPS	5.79 -61.6%
Shares Out	5.90M
PE Ratio	32.49
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	170
Open	195.55
Previous Close	187.00
Day's Range	188.25 - 195.65
52-Week Range	109.00 - 236.55
Beta	0.20
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About Makers Laboratories

Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. It operates in two segments, Pharmaceutical and Chemical Manufacturing. The company offers general health therapeutic products, including acid regulatory, anthelmintic, anti-allergic, anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeals, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensive, anti–inflammatory, analgesic, anti-spasmodic, anti-malarial, and anti-thyroid. It also provides cough and cold control, dig... [Read more]

Industry Pharmaceutical Preparations

Founded 1984

Employees 114

Stock Exchange Bombay Stock Exchange

Ticker Symbol 506919

Full Company Profile

Financial Performance

In fiscal year 2026, Makers Laboratories's revenue was 1.41 billion, an increase of 16.30% compared to the previous year's 1.21 billion. Earnings were 23.51 million, a decrease of -68.61%.

Financial Statements